News & Updates
Filter by Specialty:
Obesity, metabolic dysfunction linked to BPE in premenopausal women
A recent study has established the association of increased background parenchymal enhancement (BPE) with obesity, insulin resistance, leptin, and adiponectin in premenopausal women who are at high risk of breast cancer.
Obesity, metabolic dysfunction linked to BPE in premenopausal women
28 Feb 2023Diet, physical activity help lower cardiometabolic disease risk
Behavioural weight-loss interventions, such as diet alone and diet plus physical activity (PA), induce a beneficial change in biomarkers of insulin resistance and cardiometabolic health in adults with overweight or obesity, reports a study. However, no additional benefit has been observed with the addition of moderate-intensity PA to a diet-only intervention.
Diet, physical activity help lower cardiometabolic disease risk
27 Feb 2023Adipose tissue–targeted nanoparticles may improve treatment of obesity and atherosclerosis
Researchers from the University of Hong Kong (HKU) have developed a nanoparticle-based targeted drug delivery system that selectively transports thyroid hormone (TH) to adipose tissue, which may improve treatment of obesity and its related cardiometabolic complications by overcoming serious adverse events (AEs) associated with systematic TH administration.
Adipose tissue–targeted nanoparticles may improve treatment of obesity and atherosclerosis
27 Feb 2023Omega-3 supplementation may protect against premature death in diabetes population
Increased intake of omega-3 fatty acids is associated with lower all-cause mortality in individuals with diabetes, as reported in a study.
Omega-3 supplementation may protect against premature death in diabetes population
25 Feb 2023Tighter BP control improves pregnancy outcomes in women with DM, chronic hypertension
Further lowering blood pressure helps cut the risk of adverse perinatal events for pregnant women with pregestational diabetes mellitus (DM) and mild chronic hypertension, according to the secondary analysis of the Chronic Hypertension and Adverse Pregnancy (CHAP) study presented at SMFM 2023.